Type 2 diabetes among Sudanese youth: Rate, pattern of prescription, comorbidities, and clinical inertia
World Journal of Clinical Cases · 26.08.2026 · 14 (24)
DOI: 10.12998/wjcc.122953 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Clinical Cases, online erschienen am 26.08.2026. Verfasst von Hyder Osman Mirghani und 1 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND Type 2 diabetes among patients < 40 years is on the rise globally. These patients are prone to rapid β-cell loss, poor glycemic control, metabolic syndrome, and mortality. Few researchers have assessed young-onset type 2 diabetes, the pattern of prescription, and associated cardiovascular risks. AIM To assess this in the state of Khartoum, Sudan. METHODS This cross-sectional study was conducted among 240 type 2 diabetic patients attending two randomly selected Polyclinics in Omdurman, Sudan during July and August 2022. A structured questionnaire including age, gender, and duration of diabetes, prescribed medications, body mass index, and glycated hemoglobin (HbA1c) was used. RESULTS Out of 240 patients with type 2 diabetes 24.6% of all enrolled type 2 diabetes mellitus patients were young-onset cases (aged < 40 years), age, 55.24 ± 10.57, their body mass index (BMI) was 30.09 ± 4.65, the duration of diabetes was10.64 ± 8.23, and HbA1c was 9.37 ± 2.49, 68.3% were on metformin, 53.3% were on sulphonylureas, 49.2% were on insulin, and 10.8% were on pioglitazone. In addition, 50% of the participants were on lipid-lowering medications, and 56.7% on antihypertensive drugs. Interestingly, 57.9% were suffering from dyslipidemia, while only 50% received lipid-lowering medications. Age, HbA1c, and BMI were not significant predictors of diabetes in the young in this model. CONCLUSION One in four Sudanese patients were young with poor glycemic control polypharmacy was observed. Antidiabetic medication prescriptions were irrational with high sulphonylureas and pioglitazone, and no prescription of drugs with cardiorenal protection. Two diabetes patients should take the benefit of cardiorenal protective diabetes medications. Furthermore, larger multicenter studies investigating the barriers to good diabetes holistic care are recommended.
Zitieren
APA
Mirghani, H. O., & Alrasheed, T. (2026). Type 2 diabetes among Sudanese youth: Rate, pattern of prescription, comorbidities, and clinical inertia. World Journal of Clinical Cases, 14(24). https://doi.org/10.12998/wjcc.122953
Vancouver
Mirghani HO, Alrasheed T. Type 2 diabetes among Sudanese youth: Rate, pattern of prescription, comorbidities, and clinical inertia. World Journal of Clinical Cases. 2026;14(24). doi:10.12998/wjcc.122953
BibTeX
@article{Mirghani2026,
author = {Mirghani, Hyder Osman and Alrasheed, Tariq},
title = {Type 2 diabetes among Sudanese youth: Rate, pattern of prescription, comorbidities, and clinical inertia},
journal = {World Journal of Clinical Cases},
year = {2026},
volume = {14},
number = {24},
doi = {10.12998/wjcc.122953}
}
EUVIMED